Mirae Asset Global Investments
PRME icon

Mirae Asset Global Investments’s Prime Medicine PRME Stock Holding History

Mirae Asset Global Investments’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.8K Sell
8,078
-1,337
-14% -$4.44K ﹤0.01% 1436
2026
Q1 		$32.8K Buy
9,415
+643
+7% +$2.45K ﹤0.01% 1369
2025
Q4 		$30.4K Buy
8,772
+2,012
+30% +$8.95K ﹤0.01% 1484
2025
Q3 		$37.5K Buy
6,760
+1,688
+33% +$6.86K ﹤0.01% 1390
2025
Q2 		$12.5K Buy
5,072
+683
+16% +$1.05K ﹤0.01% 1460
2025
Q1 		$8.73K Buy
4,389
+18
+0.4% +$46 ﹤0.01% 1484
2024
Q4 		$12.7K Buy
4,371
+30
+0.7% +$105 ﹤0.01% 1488
2024
Q3 		$15K Buy
4,341
+757
+21% +$3.51K ﹤0.01% 1469
2024
Q2 		$19.1K Buy
+3,584
New +$21.7K ﹤0.01% 1384
2024
Q1 		– Sell
-21,301
Closed -$189K – 2605
2023
Q4 		$189K Sell
21,301
-1,715
-7% -$13.2K ﹤0.01% 2346
2023
Q3 		$220K Buy
23,016
+4,145
+22% +$53.8K ﹤0.01% 2256
2023
Q2 		$276K Buy
+18,871
New +$263K ﹤0.01% 2214

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

Mirae Asset Global Investments's PRME Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Prime Medicine (PRME) stake by 14% in Q2 2026, selling an estimated $4.44K and leaving 8,078 shares worth $29.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1436.

Mirae Asset Global Investments first reported a position in PRME in Q2 2023 and has held it in 12 quarters since. The position peaked at $276K in Q2 2023. 63 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Mirae Asset Global Investments held 8,078 shares of Prime Medicine worth $29.8K as of Q2 2026.
  • Mirae Asset Global Investments sold 1,337 Prime Medicine shares in Q2 2026, an estimated $4.44K.
  • Prime Medicine made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1436 holding.
  • Mirae Asset Global Investments first reported a position in Prime Medicine in Q2 2023 and has held it in 12 quarters since.
  • Mirae Asset Global Investments's Prime Medicine position peaked at $276K in Q2 2023.
  • 63 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.